Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

被引：0
|
作者：
Freiberg-Richter, Jens [1 ]
Hantzschel, Ingmar [1 ]
Jenke, Andreas [1 ]
Lorenz, Petra [1 ]
Ehninger, Gerhard [1 ]
Bornhaeuser, Martin [1 ]
机构：
[1] Univ Hosp, Med Clin 1, Dresden, Germany
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
756
引用
收藏
页码：227A / 227A
页数：1
相关论文
共 50 条
  • [41] Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings
    GB Vogelsang
    S Arai
    Bone Marrow Transplantation, 2001, 27 : 1255 - 1262
  • [42] Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis
    Atsuo Okamura
    Kimikazu Yakushijin
    Yumiko Inui
    Yohei Funakoshi
    Yuriko Kawamori
    Takanobu Shimada
    Masanori Toyoda
    Naoko Chayahara
    Naomi Kiyota
    Yutaka Fujiwara
    Toru Mukohara
    Hiroshi Matsuoka
    Katsuya Yamamoto
    Hironobu Minami
    International Journal of Hematology, 2011, 93 : 765 - 770
  • [43] Prevalence of genital graft-versus-host disease after allogeneic stem cell transplantation
    Knutsson, E. Smith
    Broman, A-K.
    Bjork, Y.
    Hallberg, D.
    Helstrom, L.
    Nilsson, O.
    Sundfeldt, K.
    Styrenius, M.
    Brune, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S127 - S127
  • [44] Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease
    Robak, Katarzyna
    Zambonelli, Joanna
    Bilinski, Jaroslaw
    Basak, Grzegorz W.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (05) : 495 - 502
  • [45] A LIMITED SAMPLING STRATEGY FOR THERAPEUTIC DRUG MONITORING OF MYCOPHENOLATE MOFETIL FOR PROPHYLAXIS OF ACUTE GRAFT VERSUS HOST DISEASE IN ALLOGENEIC STEM CELL TRANSPLANTATION
    Gota, V.
    Pathak, K.
    Mittal, S.
    Gurjar, M.
    Patil, A.
    Bagal, B.
    Khattry, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S295 - S295
  • [46] Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
    Mielcarek, M
    Martin, PJ
    Leisenring, W
    Flowers, MED
    Maloney, D
    Sandmaier, B
    Maris, M
    Storb, R
    BLOOD, 2002, 100 (11) : 175A - 175A
  • [47] GVHD prophylaxis with mycophenolate mofetil and cyclosporin A after allogeneic blood stem cell transplantation. Results of a pilot study.
    Bornhauser, M
    Thiede, HM
    Schuler, U
    Thiede, C
    Ehninger, G
    BLOOD, 1997, 90 (10) : 462 - 462
  • [48] Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings
    Neumann, F
    Graef, T
    Tapprich, C
    Vaupel, M
    Steidl, U
    Germing, U
    Fenk, R
    Hinke, A
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2005, 35 (11) : 1089 - 1093
  • [49] PROPHYLAXIS OF GRAFT VERSUS HOST DISEASE WITH CYCLOPHOSPHAMIDE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. EXPERIENCE OF A CENTER
    Lopez-Munoz, Nieves
    Sanchez, Pina Jose Maria
    Calbacho, Maria
    Vera, Guerrero Elena
    Hidalgo, Soto Marta
    Buendia, Urena Buenaven-Tura
    De Nicolas, Sol Rodrigo
    Gutierrez, Lopez de Ocariz Xabier
    Iniguez, Garcia Rodrigo
    Poza, Santaella Maria
    Zamanillo, Herreros Irene
    Martinez-Lopez, Joaquin
    HAEMATOLOGICA, 2020, 105 : 268 - 269
  • [50] Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings
    F Neumann
    T Graef
    C Tapprich
    M Vaupel
    U Steidl
    U Germing
    R Fenk
    A Hinke
    R Haas
    G Kobbe
    Bone Marrow Transplantation, 2005, 35 : 1089 - 1093
12345